Dr. Jose R. Mackliff, Presenter at World Congress Neurotalk, 2015
Dr. Mackliff presented the BEAM treatment for schizophrenia to the BIT´s 6th annual Congress (Neurotalk 2015) held in Hangzhou, China.
The World congress Neurotalk brings together basic and industry scientists, clinical investigators, academic physicians and pharmaceutical professionals with a shared goal of developing effective therapies for the most challenging neurological diseases through research studies and technology innovation. Neurotalk has already become the largest international meeting of basic, clinical, biotechnology and industry neurosciences in China.
Moreover, it is through the annual meetings that NeuroTalk aims to provide one of the world’s most informative places for all of the participants to obtain the most updated information from the presented data and discussions concerning representative issues tackled by vigorous and cutting-edge scientific investigations.
The increasingly appreciated importance of using cross disciplinary strategies to better understand concurrent pathogenic events of the central nervous system disorders and trauma requires us to integrate promising tactics enabled by marked progresses made in the fields of stem cell biology, glial biology, bioengineering and regenerative biology, in addition to neural transplantation, neuropharmacology and neurobiology. BEAM represents a leading example of the cross disciplinary approach of using psychiatry with surgery.
Dr. Jose Mackliff’s presentation was on Bilateral Electrcoagulation of Adrenal Medulla: A Pioneer Surgery for the disappearance of the Symptoms of Schizophrenia
Dr. Mackliff has been invited to present BEAM and Case Studies of BEAM surgery at the 2018 World Congress Neurotalk.